DEOKCHOL PARISH: Open Payments
NPI 1841885142 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 57 payments from 18 companies in 2025. Trend: 2023 $268 · 2024 $229 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 19 | $172 |
| AstraZeneca Pharmaceuticals LP | 7 | $156 |
| Amgen Inc. | 5 | $109 |
| Novo Nordisk Inc | 3 | $88 |
| PFIZER INC. | 3 | $70 |
| ABBVIE INC. | 3 | $53 |
| Lilly USA, LLC | 2 | $50 |
| Corcept Therapeutics | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
Products named: XYOSTED, AIRSUPRA, NURTEC ODT, FARXIGA, Korlym, QULIPTA, JARDIANCE, Ozempic.
Industry payments across NV — which companies pay providers there.
